Inactive Instrument
TCR2 Therapeutics Inc. Stock
Stocks
TCRR
US87808K1060
Biotechnology & Medical Research
| 1 day | -5.73% |
| Manager | Title | Age | Since |
|---|---|---|---|
William Bertrand
PSD | President | 61 | 01/06/2023 |
Robert Tighe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Praveen Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/06/23 | Issuer sale | Chief Technology Officer | 488,678 | 1.2447% | ||
| 01/06/23 | MPM BioImpact LLC
| Others | Company | 3,370,982 | 8.5859% | |
| 01/06/23 | Issuer sale | President and CEO; Director | 1,600,413 | 4.0763% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.73% | -15.43% | - | - | 58.11M | ||
| +0.34% | +2.06% | -10.67% | -5.26% | 43.13B | ||
| +1.73% | +7.76% | +318.08% | +543.17% | 34.65B | ||
| +0.61% | +2.77% | +10.00% | +46.44% | 30.03B | ||
| +0.02% | -7.52% | +8.45% | -21.52% | 28B | ||
| -1.06% | -2.60% | +9.08% | +21.51% | 24.45B | ||
| -1.23% | +4.56% | - | - | 14.34B | ||
| -0.99% | -2.50% | +47.29% | +106.70% | 13.14B | ||
| +1.54% | -0.94% | +6.69% | +8.40% | 12.53B | ||
| +2.39% | +3.57% | +102.86% | +83.89% | 12.25B | ||
| Average | -0.24% | +0.65% | +61.47% | +97.92% | 23.61B | |
| Weighted average by Cap. | +0.40% | +1.19% | +67.04% | +113.26% |
Employees
58
















